PK/PD modeling links accelerated resolution of COVID-19-related clinical symptoms to SARS-CoV-2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together

Ernest, CS; Chien, JY; Patel, DR; Chigutsa, E

Ernest, CS (通讯作者),Eli Lilly & Co, Global PK PD & Pharmacometr, Indianapolis, IN 46285 USA.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022; 11 (6): 721

Abstract

The relationship between severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) viral load reduction and disease symptom resolution remains larg......

Full Text Link